IP Verse

Dr Falk Pharma competitive analysis

Latest oppositions filed by Dr Falk Pharma

Explore patent oppositions filed by Dr Falk Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 16, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3574914	Corticosteroid Compositions	MERITAGE PHARMA	Sep 1, 2022
EP2585075	Methods Of Treatment For Esophageal Inflammation	MERITAGE PHARMA	May 4, 2022
EP2646003	Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods	ADARE PHARMACEUTICALS	Feb 23, 2021
EP3354276	Compositions For The Treatment Of Gastrointestinal Inflammation	MERITAGE PHARMA	Sep 23, 2020
EP3041476	Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis	ADARE I	Jul 22, 2020
EP3403654	Orally Administered Corticosteroid Compositions	ADARE I	Apr 28, 2020
EP2214679	Corticosteroid Compositions	MERITAGE PHARMA	Dec 19, 2019
EP2482822	Orally Administered Corticosteroid Compositions	ADARE I	Mar 1, 2019
EP2211896	Compositions For The Treatment Of Gastrointestinal Inflammation	MERITAGE PHARMA	Sep 27, 2018
EP2214677	Compositions For The Treatment Of Inflammation Of The Gastrointestinal Tract	MERITAGE PHARMA	May 22, 2018

Latest patents of Dr Falk Pharma opposed by its competitors

Explore Dr Falk Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 16, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP2886108	Nov 2, 2022	Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The Esophagus	1
EP3086782	Sep 26, 2018	Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus	1

Latest publications and patents of Dr Falk Pharma New

Explore the latest publications and patents granted to Dr Falk Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Oct 10, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Dr Falk Pharma
EP2886108	Nov 2, 2022	Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The Esophagus	Patent Maintained As Amended
EP3086782	Sep 26, 2018	Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus	Opposition Rejected

Latest PTAB cases involving Dr Falk Pharma

Discover the latest PTAB cases involving Dr Falk Pharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 16, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Dr Falk Pharma
PGR2025-00086	Sep 19, 2025	DR FALK PHARMA	ELLODI PHARMACEUTICALS	Pending
IPR2025-00052	Oct 24, 2024	DR FALK PHARMA	ELLODI PHARMACEUTICALS LP	Trial Instituted
IPR2025-00054	Oct 24, 2024	DR FALK PHARMA	ELLODI PHARMACEUTICALS LP	Trial Instituted
IPR2025-00055	Oct 24, 2024	DR FALK PHARMA	ELLODI PHARMACEUTICALS LP	Trial Instituted
IPR2025-00056	Oct 24, 2024	DR FALK PHARMA	ELLODI PHARMACEUTICALS LP	Trial Instituted
IPR2024-01197	Jul 22, 2024	DR FALK PHARMA	ELLODI PHARMACEUTICALS LP	Trial Instituted

Peer Comparison New

IP litigation analysis comparing Dr Falk Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 16, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
DR FALK PHARMA	10	2	6	-
ELLODI PHARMACEUTICALS	2	3	-	1
ELLODI PHARMACEUTICALS LP	-	-	-	5
MERITAGE PHARMA	-	9	-	-